NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

I agree with your 2.1%:

https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-018-1507-6
includes:

Only 2.1% of ITT patients (n?=?7) had a grade 3 or 4 adverse event that was deemed at least possibly related to the vaccine. Overall adverse events with DCVax were comparable to standard therapy alone.

After looking this up, I sent an email to the correspondence link mentioned here (www.mdpi.com/2072-6694/11/4/537/htm), requesting a correction to be made.